Photomedex Inc: (NASD: PHMD)

$16.13

0.12 (0.75%)

Volume 94,652

May 17 04:00 PM ET

Zacks Rank: 1-Strong Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		16.01 - 16.22
	
		52wk Low - High
		9.85 - 16.65
	
		Previous Close
		16.01
	
		Avg. Volume
		117,255
	
		Industry
		LASERS-SYS/COMP
	
		Market Cap
		339.44 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.25
	
		PE (Forward)
		9.60
	
		Current Year Est.
		1.68
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		1
Strong Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Outperform
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		56 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 05/13/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            9.60
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            1.68
                        
                            Current Quarter Estimate
                            0.41
                        
                            Most Accurate Estimate
                            0.41
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-07-2013
                        
                            EPS Last Year
                            1.47
                        
                            Expected Earnings Growth
                            NA
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Photomedex, Inc. develops, manufactures and markets therapeutic excimer laser-based instrumentation designed to treat psoriasis and vitiligo. They are also developing their technology for the treatment of other skin disorders. They've received the first Food and Drug Administration, or FDA, approval to market an excimer laser system, XTRAC system, for the treatment of psoriasis.  They have commercially launched the XTRAC system in the United States.   
Full PHMD Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
PHMD Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.41	0.50	1.68	NA
Number of Estimates	1	1	1	0
Low Estimate	0.41	0.50	1.68	NA
High Estimate	0.41	0.50	1.68	NA
Year Ago EPS	0.51	0.35	1.37	1.68
EPS Growth	-19.61%	42.86%	22.63%	NA

More PHMD Estimates

Average Earnings Estimates for PHMD

EPS Growth for PHMD

Industry Analysis

Name	Symbol	Previous Close
PHOTOMEDEX INC	PHMD	16.13
ELECTRO SCI IND	ESIO	11.31
BIOLASE TECH	BIOL	4.80
CUTERA INC	CUTR	9.20
CYNOSURE INC-A	CYNO	24.15
GSI GROUP INC	GSIG	8.22
II-VI INCORP	IIVI	16.42
IPG PHOTONICS	IPGP	61.78
IRIDEX CORP	IRIX	6.12
MICROVISION INC	MVIS	2.65

Sector:Computer and Technology>> Industry:LASERS-SYS/COMP

COMPARE TICKER vs. Its Peers

Zacks Commentary

PhotoMedex Inc. Enters Oversold Territory

Jan 30, 2013

PhotoMedex

Jan, 18 2013 00:00

Report for PHMD

May 13, 2013

More PHMD Zacks Commentary

Financials

EPS TTM	1.47
Sales	221
Net Income	25
Price/Earnings	10.97
Price/Book	2.07
Price/Cash Flow	10.14
Price/Sales	1.49

More PHMD Financials

News

Is Photomedex Poised for a Short Squeeze? - GuruFocus

Apr 16, 2013

PhotoMedex, Inc. (PHMD) CEO Dolev Rafaeli sells 140,000 Shares - GuruFocus

Mar 15, 2013

Ascendiant Capital Raises PT on Photomedex After Better Than Expected Q4 Results - Benzinga

Mar 14, 2013

UPDATE: Canaccord Raises PT to $19.50 on PhotoMedex on Solid Q412 Earnings Beat - Benzinga

Mar 14, 2013

5 Stocks Rising on Unusual Volume - TheStreet.com

Mar 13, 2013

Earnings Scheduled For March 13, 2013 - Benzinga

Mar 13, 2013

PhotoMedex shifts to Q4 profit - Investors Business Daily

Mar 13, 2013

PhotoMedex, Inc. (PHMD) CEO, 10% Owner Dolev Rafaeli sells 40,429 Shares - GuruFocus

Mar 12, 2013

See All News Stories on PHMD

Broker Recommendations

Current ABR	1.33
ABR (Last Week)	1.33
# of recs in ABR	3
Average Target Price	23.75
Industry Rank by ABR	56 out of 265
Rank in Industry	1 out of 13

More PHMD Broker Recommendations

Username: Password:

Remember me [?]

Forgot Password

New Member

Photomedex Inc: (NASD: PHMD)

$16.13

0.12 (0.75%)

Volume 94,652

May 17 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Computer and Technology>> Industry:LASERS-SYS/COMP

Zacks Commentary

PhotoMedex Inc. Enters Oversold Territory

PhotoMedex

Report for PHMD

Financials

News

Is Photomedex Poised for a Short Squeeze? - GuruFocus

PhotoMedex, Inc. (PHMD) CEO Dolev Rafaeli sells 140,000 Shares - GuruFocus

Ascendiant Capital Raises PT on Photomedex After Better Than Expected Q4 Results - Benzinga

UPDATE: Canaccord Raises PT to $19.50 on PhotoMedex on Solid Q412 Earnings Beat - Benzinga

5 Stocks Rising on Unusual Volume - TheStreet.com

Earnings Scheduled For March 13, 2013 - Benzinga

PhotoMedex shifts to Q4 profit - Investors Business Daily

PhotoMedex, Inc. (PHMD) CEO, 10% Owner Dolev Rafaeli sells 40,429 Shares - GuruFocus

Broker Recommendations

Day Low - High	16.01 - 16.22
52wk Low - High	9.85 - 16.65
Previous Close	16.01
Avg. Volume	117,255
Industry	LASERS-SYS/COMP
Market Cap	339.44 M
Div - Yield	0.00 - 0.00
Beta	0.25
PE (Forward)	9.60
Current Year Est.	1.68
Quarterly Earnings ESP	0.00%

PE (Forward)	9.60
PEG Ratio	NA
Current Year Est.	1.68
Current Quarter Estimate	0.41
Most Accurate Estimate	0.41
Earnings ESP	0.00%
Next Earnings Report Date	08-07-2013
EPS Last Year	1.47
Expected Earnings Growth	NA